1. Althagafi I, Farghaly TA, Abbas EMH, Harras MF. Benzosuberone as Precursor for Synthesis of Antimicrobial Agents: Synthesis, Antimicrobial Activity, and Molecular Docking. Polycycl Aromat Compd. 2021;41(8):1646-66.
2. Kumar H, Kumar P, Narasimhan B, Ramasamy K, Mani V, Mishra RK, et al. Synthesis, in vitro antimicrobial, antiproliferative, and QSAR studies of N-(substituted phenyl)-2/4-(1H-indol-3-ylazo)-benzamides. Med Chem Res. 2013;22:1957-71.
3. Zamperini C, Maccari G, Deodato D, Pasero C, D’Agostino I, Orofino F, et al. Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents. Sci Rep. 2017;7:8251.
4. Keche AP, Hatnapure GD, Tale RH, Rodge AH, Birajdar SS, Kamble VM. Novel pyrimidine derivatives with aryl urea, thiourea and sulfonamide moieties: synthesis, anti-infammatory and antimicrobial evaluation. Bioorg Med Chem Lett. 2012;22(10):3445–48.
5. Sharma D, Kumar S, Narasimhan B, Ramasamy K, Lim SM, Shah SAA, et al. 4‑(4‑Bromophenyl)‑thiazol‑2‑amine derivatives: synthesis, biological activity and molecular docking study with ADME profile. BMC Chem. 2019;13:60.
6. Sharma D, Kumar S, Narasimhan B, Ramasamy K, Lim SM, Shah SAA, et al. Synthesis, molecular modelling and biological significance of N‑(4‑(4‑bromophenyl)thiazol‑2‑yl) ‑2‑chloroacetamide derivatives as prospective antimicrobial and antiproliferative agents. BMC Chem. 2019;13:46.
7. Tahlan S, Kumar S, Ramasamy K, Lim SM, Ali Shah SA, Vasudevan M, et al. In‑silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents. BMC Chem. 2019;13:90.
8. Trotsko N, Kosikowska U, Paneth A, Plech T, Malm A, Wujec M. Synthesis and Antibacterial Activity of New Thiazolidine-2,4-dione-Based Chlorophenylthiosemicarbazone Hybrids. Molecules. 2018;23(5):1023.
9. Parekh NM, Juddhawala KV, Rawal BM. Antimicrobial activity of thiazolyl benzene sulfonamide-condensed 2,4-thiazolidinediones derivatives. Med Chem Res. 2012;22:2737–45.
10. Jiang B, Luo J, Guo S, Wang L. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties. Bioorg Chem. 2021;108:104648.
11. Fettach S, Thari FZ, Hafidi Z, Karrouchi K, Bouathmany K, Cherrah Y, et al. Biological, toxicological and molecular docking evaluations of isoxazoline-thiazolidine-2,4-dione analogues as new class of anti-hyperglycemic agents. J Biomol Struct Dyn. 2021; https://doi.org/10.1080/07391102.2021.2017348.
12. Mohd Siddique MU, Thakur A, Shilkar D, Yasmin S, Halakova D, Kovacikova L, et al. Non-Carboxylic Acid Inhibitors of Aldose Reductase Based on N-Substituted Thiazolidinedione Derivatives. Eur J Med Chem. 2021;223:113630.
13. Abdellatif KRA, Fadaly WAA, Kamel GM, Elshaier, YAMM, El-Magd MA. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors. Bioorg Chem. 2019;82:86-99.
14. Elkamhawy A, Kim NY, Hassan AHE. Park JE, Paik S, Yang JE, et al. Thiazolidine-2,4-dione-based irreversible allosteric IKK-β kinase inhibitors: Optimization into in vivo active anti-inflammatory agents. Eur J Med Chem. 2020;188:111955.
15. Asati V, Bajaj S, Mahapatra DK, Bharti SK. Molecular Modeling Studies of Some Thiazolidine-2,4-Dione Derivatives as 15-PGDH Inhibitors. Med Chem Res. 2015;25(1): 94-108.
16. Yu I, Choi D, Lee HK, Cho H. Synthesis and Biological Evaluation of New Benzylidenethiazolidine-2,4-Dione Derivatives as 15-Hydroxyprostaglandin Dehydrogenase Inhibitors to Control the Intracellular Levels of Prostaglandin E2 for Wound Healing. Biotechnol Bioprocess Eng. 2019;24(3):464-75.
17. Ibrahim HS, Abdelsalam M, Zeyn Y, Zessin M, Mustafa AHM, Fischer MA, et al. Synthesis, molecular docking and biological characterization of pyrazine linked 2-aminobenzamides as new class i selective histone deacetylase (hdac) inhibitors with anti-leukemic activity. Int J Mol Sci. 2022;23:369.
18. El-Kashef H, Badr G, Abo El-Maali N, Sayed D, Melnyk P, Lebegue N, et al. Synthesis of a novel series of (Z)-3,5-disubstituted thiazolidine-2,4-diones as promising anti-breast cancer agents. Bioorg Chem. 2020;96:103569.
19. Sharma RK, Younis Y, Mugumbate G, Njoroge M, Gut J, Rosenthal PJ. et al. Synthesis and structure activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2. Eur J Med Chem. 2015;90:507–18.
20. Ratnaparkhi H, Thakar S, Bansode D. An overview of chemistry and antitubercular activity of thiazolidinediones. Sch Acad J Pharm. 2020;9(1):23-31.
21. Trotsko N, Golus J, Kazimierczak P, Paneth A, Przekora A, Ginalska G, et al. Synthesis and antimycobacterial activity of thiazolidine-2,4-dione based derivatives with halogenbenzohydrazones and pyridinecarbohydrazones substituents. Eur J Med Chem. 2020;189:112045.
22. Mohammed Iqbal AK, Khan AY, Kalashetti MB, Belavagi NS, Gong YD, Khazi IAM. Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring. Eur J Med Chem. 2012;53:308-15.
23. Bahare RS, Ganguly S, Choowongkomon K, Seetaha S. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2, 4-thiazolidinediones. DARU J Pharm Sci. 2015:23(1):6.
24. Aziz HA, El‑Saghier AMM, Badr M, Abuo‑Rahma GEDA, Shoman ME. Thiazolidine‑2,4‑dione‑linked ciprofloxacin derivatives with broad‑spectrum antibacterial, MRSA and topoisomerase inhibitory activities. Mol Divers. 2021; https://doi.org/10.1007/s11030-021-10302-7.
25. Alegaon SG, Venkatasubramanian U , Alagawadi KR, Kumar D, Kavalapure RS, Ranade SD, et al. Synthesis, molecular docking and ADME studies of thiazole-thiazolidinedione hybrids as antimicrobial agents. J Biomol Struct Dyn. 2021; https://doi.org/10.1080/07391102.2021.1880479.
26. Moorthy P, Ekambaram SP, Perumal SS. Synthesis, characterization and antimicrobial evaluation of imidazolyl thiazolidinedione derivatives. Arab J Chem. 2019;12(3):413–19.
27. Kumar H, Deep A, Marwaha RK. Design, synthesis, in silico studies and biological evaluation of 5‑((E)‑4‑((E)‑(substituted aryl/alkyl)methyl)benzylidene)thiazolidine‑2,4‑dione derivatives. BMC Chem. 2020;14:25.
28. Sameeh MY, Khowdiary MM, Nassar HS, Abdelall MM, Alderhami SA, Elhenawy AA. Discovery potent of thiazolidinedione derivatives as antioxidant,
α-amylase inhibitor and antidiabetic agent. Biomedicines. 2022;10:24.
29. Kumar S, Lim SM, Ramasamy K, Vasudevan M, Ali Shah SA, Selvaraj M, et al. Synthesis, molecular docking and biological evaluation of bis-pyrimidine Schiff base derivatives. Chem Cent J. 2017;11:89.
30. Kumar S, Kaushik A, Narasimhan B, Ali Shah SA, Lim SM, Ramasamy K, et al. Molecular docking, synthesis and biological significance of pyrimidine analogues as prospective antimicrobial and antiproliferative agents. BMC Chem. 2019;13:85.
31. Perumal P, Pandey VP, Parasuraman P. Docking studies on some novel piperidine analogues against DNA gyrase enzyme. Inventi Rapid Molecular Modeling. 2014;1:1-4.
32. Koehler MFT, Bergeron P, Blackwood EM, Bowman K, Clark KR, Firestein R, et al. Development of a potent, specific CDK8 kinase inhibitor which phenocopies CDK8/19 knockout cells. ACS Med Chem Lett. 2016;7:223–28.
33. Wang J, Urban L, Bojanic D. Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety. Expert Opin Drug Metab Toxicol. 2007;3(5):641-65.
34. Gleeson MP, Hersey A, Hannongbua S. In-Silico ADME Models: A general assessment of their utility in drug discovery applications. Curr Top Med Chem. 2011;11(4):358-81.
35. Li AP. Screening for human ADME/Tox drug properties in drug discovery. Res Focus. 2001;6(7):357–66.
36. Nyaki HY, Mahmoodi NO. Synthesis and characterization of derivatives including thiazolidine-2,4-dione/1-H- imidazole and evaluation of antimicrobial, antioxidant, and cytotoxic properties of new synthetic heterocyclic compounds. Res Chem Intermed. 2021;47:4129-55.
37. Mardani-Ghahfarokhi A, Farhoosh R. Antioxidant activity and mechanism of inhibitory action of gentisic and α-resorcylic acids. Sci Rep. 2020;10:19487.
38. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, et al. Antioxidant activities and oxidative stress by products in human hypertension. J Hypertens. 2003;1(1):1096-109.
39. Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. 2015;22;20(7):13384-421.
40. Wang JC. Untangling the double helix: DNA entanglement and the action of the DNA topoisomerases. Cold Spring Harbor, New York, 2019.
41. Maxwell A, Lawson DM. The ATP binding site of type II topoisomerases as a target for antibacterial drugs. Curr Top Med Chem. 2003;3:283–303.
42. Kalra S, Joshi G, Munshi A, Kumar R. Structural insights of cyclin dependent kinases: implications in design of selective inhibitors. Eur J Med Chem. 2017;142:424–58.
43. Offermann A, Joerg V, Becker F, Roesch MC, Kang D, Lemster A-L, et al. Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer. Am J Pathol. 2022;192:813-23.
44. Glide, Schrödinger, LLC, New York, NY, 2020
45. Bassyouni F, El Hefnawi M, El Rashed A, Rehim MA. Molecular modeling and biological activities of new potent antimicrobial, anti-inflammatory and anti-nociceptive of 5-nitro indoline-2-one derivatives. Drug Des. 2017;6(2):1-6.
46. QikProp, Schrödinger, LLC, New York, NY, 2020
47. Deep A, Jain S, Sharma PC, Mittal SK, Phogat P, Malhotra M. Synthesis, characterization and antimicrobial evaluation of 2,5-disubstituted-4-thiazolidinone derivatives. Arab J Chem. 2014;7:287-91.
48. Cappuccino JC, Sherman N. Microbiology-a laboratory manual. California: Addison Wesley; 1999. p 263.
49. Pharmacopoeia of India, vol.-Ӏ. New Delhi: Controller of publication, ministry of health department, Govt. of India; 2007. p. 37.
50. Koppireddi S, Komsani JR, Avula S, Pombala S, Vasamsetti S, Kotamraju S, et al. Novel 2-(2,4-dioxo-1,3-thiazolidin-5-yl)acetamides as antioxidant and/or anti-inflammatory compounds. Eur J Med Chem. 2013;66:305-13.
51. Jas MJS, Marimuthu G, Prithivirajan B. Hydrazone Analogues: Molecular Modeling, Synthesis, In- vivo Anti-Nociceptive Activity and in-vitro Antimicrobial Activity. Egypt J Chem. 2019;62(8):1441-50.
52. Singh J, Kumar M, Mansuri R, Sahoo GC, Deep A. Inhibitor designing, virtual screening and docking studies for methyltrans-ferase: a potential target against dengue virus. J Pharm Bioallied Sci. 2016;8(3):188-94.
53. Joseph A, Shah CKS, Kumar SS, Alex AT, Maliyakkal N, Moorkoth S, et al. Synthesis, in vitro anticancer and antioxidant activity of thiadiazole substituted thiazolidin-4-ones. Acta Pharm. 2013; 63:397–408.